Postdoctoral Researcher
Pharmacology · South Korea · 2025-06-13
Proposed Endeavor
The petitioner proposes to continue her research in pharmacology, specifically focusing on assessing the pharmacokinetic properties of novel medications using in vitro and in vivo models to minimize adverse drug effects and maximize efficacy for conditions such as diabetes, Alzheimer’s, and cancer.
Framework Evaluation
3 of 3 criteria metThe endeavor addresses the 90% failure rate of clinical trials and the multi-billion dollar economic burden of adverse drug reactions in the U.S. healthcare system.
The petitioner has a strong record of 13 publications and 163 citations, with papers ranking in the top 1% of the field, demonstrating significant influence in pharmacology.
The petitioner's contributions to safer drug formulations and more reliable preclinical testing provide significant public health and economic benefits that justify waiving the labor certification.
Why This Petition Was Approved
Evidence
Similar Cases
Postdoctoral Researcher
Biotechnology · China
Others
Pharmaceuticals · South Korea
Research Scientist
Pharmaceuticals · China
Others
Pharmaceuticals · China
Frequently Asked Questions
Browse More Cases
Case data sourced from publicly available petition decisions and case studies. Decision date: 2025-06-13.
Browse all casesAt a Glance
EB-2 (NIW) Case Data
Scraped Case Data
Related Pages
Get Case Insights
Compare your profile against thousands of real petition outcomes. Join the waitlist for personalized analysis.
Join Waitlist